IRRITABLE BOWEL SYNDROME TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Market Segmentation

• By Type Insights (Revenue, USD Bn, 2021 - 2033)

  • Irritable Bowel Syndrome with Constipation (IBS-C)
  • Irritable Bowel Syndrome with Diarrhea (IBS-D)
  • Mixed Irritable Bowel Syndrome (IBS-M)

• By Indication Insights (Revenue, USD Bn, 2021 - 2033)

  • Abdominal Pain
  • Bloating
  • Constipation and Diarrhea
  • Altered Bowel Habits
  • Others

• By Drug Class Insights (Revenue, USD Bn, 2021 - 2033)

  • Antispasmodics
  • Laxatives
  • Antidiarrheal Medications
  • 5-HT3 Receptor Antagonists
  • Guanylate Cyclase-C Agonists
  • Anticholinergic
  • Probiotics
  • Antidepressants
  • Antibiotics
  • Dietary Supplements
  • Others

• By Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)

  • Oral
  • Rectal
  • Parenteral

• By Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

• Regional Insights (Revenue, USD Bn, 2021 - 2033)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa